サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1588460

コンプレッサー式ネブライザーの市場規模、シェア、動向分析レポート：適応症別、最終用途別、地域別、セグメント予測、2025年～2030年

Pneumatic Nebulizers Market Size, Share & Trends Analysis Report By Indication (Breath-actuated, Vented), By End-use (Hospitals & Clinics, Home Healthcare), By Region, And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 100 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
コンプレッサー式ネブライザーの市場規模、シェア、動向分析レポート：適応症別、最終用途別、地域別、セグメント予測、2025年～2030年
出版日: 2024年10月09日
発行: Grand View Research
ページ情報: 英文 100 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

コンプレッサー式ネブライザー市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界のコンプレッサー式ネブライザー市場規模は2025年から2030年にかけてCAGR 6.5％を記録し、2030年には11億6,674万米ドルに達すると予測されています。

近年、家庭用ヘルスケア機器が人気を集めているため、市場はコンプレッサー式ネブライザーの採用で一定の伸びを示しています。製品の小型化や技術の進歩も在宅ヘルスケア機器の採用を後押ししています。

ミネソタ州保健省によれば、ネブライザーを使った薬剤投与は、他のエアロゾルを発生させる処置に比べて感染リスクが低いです。一方、ISAMによれば、ネブライザーからのエアロゾルは、非患者源であるネブライズチャンバー内の液体から発生するため、患者由来のウイルス粒子を運ぶことはないです。ネブライザーから発生するエアロゾルが病原体を含むのは、ヘルスケアワーカーまたは患者がネブライザーを汚染した場合のみです。パンデミック時にネブライザーを使用することが適切かどうかについては、各機関のさまざまな勧告でも明確になっていないです。

しかし、ネブライザーによる受動感染の事例は知られていないです。また、感染の危険性があるとしても、COVID-19の適切な予防措置をとれば回避できます。したがって、パンデミックは市場全体に一定の影響を与えたに過ぎないです。革命的な技術進歩が市場を急速に変化させています。こうした拡大は、有利な可能性を生み出しています。例えば、2019年3月、Breath Technologiesは、調査中のPARI Pharmaの薬剤特異的eFlowネブライザーを介した閉塞性細気管支炎症候群の治療に対するL-CSA-iの第3相BOSTON臨床試験の開始を発表しました。

コンプレッサー式ネブライザー市場レポートハイライト

  • 適応症に基づくと、呼吸作動式セグメントが2024年に最大の収益シェア64.06%を占めました。呼吸作動式ネブライザーは、より高いドラッグデリバリー能力と少ない投与量の浪費の特徴を解明しています。したがって、高度な吸入療法を提供するセグメントは、予測期間にわたって市場を独占すると予想されます。
  • 病院・診療所セグメントは2024年に最大の市場シェアを占めました。喘息や慢性閉塞性肺疾患（COPD）などの急性呼吸器疾患の管理にコンプレッサー式ネブライザーの採用が増加していることが、同分野の成長に拍車をかけています。
  • 北米のコンプレッサー式ネブライザー市場は、2024年に35.28％の収益シェアで支配的であり、呼吸器疾患の有病率の増加とネブライザ技術の進歩により、予測期間中に成長する見込みです。
  • アジア太平洋地域は、予測期間中に最も速いCAGRで成長すると予想されます。アジアにおけるCOPDの負担は欧米先進諸国よりも大きいです。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 市場の変数、動向、範囲

  • 市場系統の見通し
  • 市場力学
    • 市場 促進要因分析
    • 市場抑制要因分析
    • 市場機会分析
    • 市場課題分析
    • 業界分析- ポーターのファイブフォース分析
    • PESTLE分析

第4章 適応症ビジネス分析

  • 適応症市場シェア、2024年および2030年
  • 適応症セグメントダッシュボード
  • 市場規模と予測および動向分析、適応症別、2018～2030年
  • 呼吸作動型
  • ベント

第5章 最終用途ビジネス分析

  • 最終用途市場シェア、2024年および2030年
  • 最終用途セグメントダッシュボード
  • 市場規模と予測および動向分析、最終用途別、2018～2030年
  • 病院・クリニック
  • 在宅ヘルスケア

第6章 地域推定・動向分析

  • 地域別市場シェア分析、2024年および2030年
  • 地域市場ダッシュボード
  • 市場規模、予測動向分析、2018年から2030年：
  • 北米
    • 北米のコンプレッサー式ネブライザー市場推計・予測、2018年-2030年
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 欧州のコンプレッサー式ネブライザー市場推計・予測、2018年-2030年
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • ノルウェー
    • デンマーク
    • スウェーデン
  • アジア太平洋
    • アジア太平洋地域のコンプレッサー式ネブライザー市場推計・予測、2018年-2030年
    • 日本
    • 中国
    • インド
    • 韓国
    • オーストラリア
    • タイ
  • ラテンアメリカ
    • ラテンアメリカのコンプレッサー式ネブライザー市場推計・予測、2018年-2030年
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 中東・アフリカ空気圧ネブライザー市場推計・予測、2018-2030
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第7章 競合情勢

  • 参入企業概要
  • 企業の市況分析
  • 企業分類
  • 戦略マッピング
  • 企業プロファイル
    • Koninklijke Philips NV
    • OMRON Corporation
    • Cook Medical PARI GmbH
    • General Electric
    • Allied Healthcare Products, Inc.
    • BD（Becton, Dickinson &Company）
    • GF Health Products, Inc.
    • Medline Industries, LP
    • Briggs Healthcare
    • Vectura Group Ltd
図表

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 4 North America pneumatic nebulizers market, by country, 2018 - 2030 (USD Million)
  • Table 5 North America pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 6 North America pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 7 U.S. pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 8 U.S. pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 9 Canada pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 10 Canada pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 11 Mexico pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 12 Mexico pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 13 Europe pneumatic nebulizers market, by country, 2018 - 2030 (USD Million)
  • Table 14 Europe pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 15 Europe pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 16 UK pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 17 UK pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 18 Germany pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 19 Germany pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 20 France pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 21 France pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 22 Italy pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 23 Italy pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 24 Spain pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 25 Spain pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 26 Norway pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 27 Norway pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 28 Denmark pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 29 Denmark pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 30 Sweden pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 31 Sweden pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 32 Asia Pacific pneumatic nebulizers market, by country, 2018 - 2030 (USD Million)
  • Table 33 Asia Pacific pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 34 Asia Pacific pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 35 Japan pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 36 Japan pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 37 China pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 38 China pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 39 India pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 40 India pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 41 Australia pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 42 Australia pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 43 South Korea pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 44 Thailand pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 45 Thailand pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 46 Latin America pneumatic nebulizers market, by country, 2018 - 2030 (USD Million)
  • Table 47 Latin America pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 48 Latin America pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 49 Brazil pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 50 Brazil pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 51 Argentina pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 52 Argentina pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 53 Middle East & Africa pneumatic nebulizers market, by country, 2018 - 2030 (USD Million)
  • Table 54 Middle East & Africa pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 55 MEA pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 56 South Africa pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 57 South Africa pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 58 Saudi Arabia pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 59 Saudi Arabia pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 60 UAE pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 61 UAE pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 62 Kuwait pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 63 Kuwait pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Market segmentation
  • Fig. 8 Market snapshot
  • Fig. 9 Segment snapshot
  • Fig. 10 Competitive landscape snapshot
  • Fig. 11 Market trends & outlook
  • Fig. 12 PESTLE analysis
  • Fig. 13 Porter's five forces analysis
  • Fig. 14 Pneumatic nebulizers market: Indication outlook and key takeaways
  • Fig. 15 Pneumatic nebulizers market: Indication movement analysis
  • Fig. 16 Breath-actuated market, 2018 - 2030 (USD Million)
  • Fig. 17 Vented market, 2018 - 2030 (USD Million)
  • Fig. 18 Pneumatic nebulizers market: End use outlook and key takeaways
  • Fig. 19 Pneumatic nebulizers market: End use movement analysis
  • Fig. 20 Hospitals & clinics market, 2018 - 2030 (USD Million)
  • Fig. 21 Home healthcare market, 2018 - 2030 (USD Million)
  • Fig. 22 Regional marketplace: Key takeaways
  • Fig. 23 Regional outlook, 2024 & 2030
  • Fig. 24 Pneumatic nebulizers market: Region movement analysis
  • Fig. 25 North America pneumatic nebulizers market, 2018 - 2030 (USD Million)
  • Fig. 26 U.S. pneumatic nebulizers market, 2018 - 2030 (USD Million)
  • Fig. 27 Canada pneumatic nebulizers market, 2018 - 2030 (USD Million)
  • Fig. 28 Mexico pneumatic nebulizers market, 2018 - 2030 (USD Million)
  • Fig. 29 Europe pneumatic nebulizers market, 2018 - 2030 (USD Million)
  • Fig. 30 UK pneumatic nebulizers market, 2018 - 2030 (USD Million)
  • Fig. 31 Germany pneumatic nebulizers market, 2018 - 2030 (USD Million)
  • Fig. 32 France pneumatic nebulizers market, 2018 - 2030 (USD Million)
  • Fig. 33 Italy pneumatic nebulizers market, 2018 - 2030 (USD Million)
  • Fig. 34 Spain pneumatic nebulizers market, 2018 - 2030 (USD Million)
  • Fig. 35 Spain pneumatic nebulizers market, 2018 - 2030 (USD Million)
  • Fig. 36 Norway pneumatic nebulizers market, 2018 - 2030 (USD Million)
  • Fig. 37 Denmark pneumatic nebulizers market, 2018 - 2030 (USD Million)
  • Fig. 38 Sweden pneumatic nebulizers market, 2018 - 2030 (USD Million)
  • Fig. 39 Asia Pacific pneumatic nebulizers market, 2018 - 2030 (USD Million)
  • Fig. 40 Japan pneumatic nebulizers market, 2018 - 2030 (USD Million)
  • Fig. 41 China pneumatic nebulizers market, 2018 - 2030 (USD Million)
  • Fig. 42 India pneumatic nebulizers market, 2018 - 2030 (USD Million)
  • Fig. 43 Australia pneumatic nebulizers market, 2018 - 2030 (USD Million)
  • Fig. 44 South Korea pneumatic nebulizers market, 2018 - 2030 (USD Million)
  • Fig. 45 Thailand pneumatic nebulizers market, 2018 - 2030 (USD Million)
  • Fig. 46 Latin America pneumatic nebulizers market, 2018 - 2030 (USD Million)
  • Fig. 47 Brazil pneumatic nebulizers market, 2018 - 2030 (USD Million)
  • Fig. 48 Argentina pneumatic nebulizers market, 2018 - 2030 (USD Million)
  • Fig. 49 Middle East and Africa pneumatic nebulizers market, 2018 - 2030 (USD Million)
  • Fig. 50 South Africa pneumatic nebulizers market, 2018 - 2030 (USD Million)
  • Fig. 51 Saudi Arabia pneumatic nebulizers market, 2018 - 2030 (USD Million)
  • Fig. 52 UAE pneumatic nebulizers market, 2018 - 2030 (USD Million)
  • Fig. 53 Kuwait pneumatic nebulizers market, 2018 - 2030 (USD Million)
  • Fig. 54 Company categorization
  • Fig. 55 Strategy mapping
  • Fig. 56 Company market position analysis
目次
Product Code: GVR-1-68038-194-8

Pneumatic Nebulizers Market Growth & Trends:

The global pneumatic nebulizers market size is expected to reach USD 1,166.74 million by 2030, registering a CAGR of 6.5% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market has shown constant growth in the adoption of pneumatic nebulizers as home healthcare devices have been gaining popularity in recent years. Miniaturization of products and technological advancements are also boosting the adoption of home healthcare devices.

As per the Minnesota Department of Health, administration of medication through nebulizer represents a lower infection risk as compared to other aerosol-producing procedures. On the other hand, according to ISAM, aerosols from the nebulizer do not carry viral particles derived from the patient as they are generated from the fluid in the nebulized chamber, which is a non-patient source. Aerosols generated by nebulizers comprise pathogens only when the healthcare workers or patients contaminate the nebulizers. Various recommendations from institutes do not clarify whether it is appropriate to use nebulizers during the pandemic.

However, there are no known cases of passive infection due to nebulizers. Also, the risk of infection, if any, can be avoided if proper COVID-19 precautions are taken. Therefore, the pandemic affected the overall market only to a certain extent. Revolutionary technological progress is rapidly transforming the market. These expansions are producing lucrative potentials. For instance, in March 2019, Breath Technologies announced the initiation of Phase 3 BOSTON clinical study of L-CsA-i for the treatment of bronchiolitis obliterans syndrome via a drug-specific eFlow nebulizer of PARI Pharma that is under investigation.

Pneumatic Nebulizers Market Report Highlights:

  • Based on indication, the breath-actuated segment held the largest revenue share 64.06% in 2024. Breath-actuated nebulizers elucidate higher drug delivery capacity and lesser dosage wastage features. Thus, the segment delivering advanced inhalation therapy is expected to dominate the market over the forecast period.
  • Hospitals & clinics segment held the largest market share in 2024. The increasing adoption of pneumatic nebulizers for the management of acute respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD) is fueling the segment growth.
  • North America pneumatic nebulizers market dominated with a revenue share of 35.28% in 2024 and is poised to grow over the forecast period owing to the increasing prevalence of respiratory diseases and advancements in nebulizer technology.
  • Asia Pacific is expected to grow at the fastest CAGR over the forecast period. The burden of COPD in Asia is greater than that in developed Western countries.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Indication
    • 1.2.2. End Use
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
    • 3.2.3. Market Opportunity Analysis
    • 3.2.4. Market Challenge Analysis
    • 3.2.5. Industry Analysis - Porter's Five Forces Analysis
      • 3.2.5.1. Supplier power
      • 3.2.5.2. Buyer power
      • 3.2.5.3. Substitution threat
      • 3.2.5.4. Threat of new entrant
      • 3.2.5.5. Competitive rivalry
    • 3.2.6. PESTLE Analysis

Chapter 4. Indication Business Analysis

  • 4.1. Indication Market Share, 2024 & 2030
  • 4.2. Indication Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Indication, 2018 to 2030 (USD Million)
  • 4.4. Breath-actuated
    • 4.4.1. Breath-actuated market, 2018 - 2030 (USD Million)
  • 4.5. Vented
    • 4.5.1. Vented market, 2018 - 2030 (USD Million)

Chapter 5. End Use Business Analysis

  • 5.1. End Use Market Share, 2024 & 2030
  • 5.2. End Use Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 5.4. Hospitals & Clinics
    • 5.4.1. Hospitals & clinics market, 2018 - 2030 (USD Million)
  • 5.5. Home Healthcare
    • 5.5.1. Home healthcare market, 2018 - 2030 (USD Million)

Chapter 6. Regional Estimates & Trend Analysis

  • 6.1. Regional Market Share Analysis, 2024 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 6.4. North America
    • 6.4.1. North America pneumatic nebulizers market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. U.S.
      • 6.4.2.1. Key country dynamic
      • 6.4.2.2. Regulatory framework/reimbursement scenario
      • 6.4.2.3. U.S. pneumatic nebulizers market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. Canada
      • 6.4.3.1. Key country dynamic
      • 6.4.3.2. Regulatory framework/reimbursement scenario
      • 6.4.3.3. Canada pneumatic nebulizers market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. Mexico
      • 6.4.4.1. Key country dynamic
      • 6.4.4.2. Regulatory framework/reimbursement scenario
      • 6.4.4.3. Mexico pneumatic nebulizers market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.5. Europe
    • 6.5.1. Europe pneumatic nebulizers market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. UK
      • 6.5.2.1. Key country dynamic
      • 6.5.2.2. Regulatory framework/reimbursement scenario
      • 6.5.2.3. UK pneumatic nebulizers market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Germany
      • 6.5.3.1. Key country dynamic
      • 6.5.3.2. Regulatory framework/reimbursement scenario
      • 6.5.3.3. Germany pneumatic nebulizers market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.4. France
      • 6.5.4.1. Key country dynamic
      • 6.5.4.2. Regulatory framework/reimbursement scenario
      • 6.5.4.3. France pneumatic nebulizers market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.5. Italy
      • 6.5.5.1. Key country dynamic
      • 6.5.5.2. Regulatory framework/reimbursement scenario
      • 6.5.5.3. Italy pneumatic nebulizers market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.6. Spain
      • 6.5.6.1. Key country dynamic
      • 6.5.6.2. Regulatory framework/reimbursement scenario
      • 6.5.6.3. Spain pneumatic nebulizers market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.7. Norway
      • 6.5.7.1. Key country dynamic
      • 6.5.7.2. Regulatory framework/reimbursement scenario
      • 6.5.7.3. Norway pneumatic nebulizers market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.8. Denmark
      • 6.5.8.1. Key country dynamic
      • 6.5.8.2. Regulatory framework/reimbursement scenario
      • 6.5.8.3. Denmark pneumatic nebulizers market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.9. Sweden
      • 6.5.9.1. Key country dynamic
      • 6.5.9.2. Regulatory framework/reimbursement scenario
      • 6.5.9.3. Sweden pneumatic nebulizers market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.6. Asia Pacific
    • 6.6.1. Asia Pacific pneumatic nebulizers market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. Japan
      • 6.6.2.1. Key country dynamic
      • 6.6.2.2. Regulatory framework/reimbursement scenario
      • 6.6.2.3. Japan pneumatic nebulizers market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. China
      • 6.6.3.1. Key country dynamic
      • 6.6.3.2. Regulatory framework/reimbursement scenario
      • 6.6.3.3. China pneumatic nebulizers market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. India
      • 6.6.4.1. Key country dynamic
      • 6.6.4.2. Regulatory framework/reimbursement scenario
      • 6.6.4.3. India pneumatic nebulizers market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. South Korea
      • 6.6.5.1. Key country dynamic
      • 6.6.5.2. Regulatory framework/reimbursement scenario
      • 6.6.5.3. South Korea pneumatic nebulizers market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.6.6. Australia
      • 6.6.6.1. Key country dynamic
      • 6.6.6.2. Regulatory framework/reimbursement scenario
      • 6.6.6.3. Australia pneumatic nebulizers market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.6.7. Thailand
      • 6.6.7.1. Key country dynamic
      • 6.6.7.2. Regulatory framework/reimbursement scenario
      • 6.6.7.3. Thailand pneumatic nebulizers market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.7. Latin America
    • 6.7.1. Latin America pneumatic nebulizers market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.7.2. Brazil
      • 6.7.2.1. Key country dynamic
      • 6.7.2.2. Regulatory framework/reimbursement scenario
      • 6.7.2.3. Brazil pneumatic nebulizers market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.7.3. Argentina
      • 6.7.3.1. Key country dynamic
      • 6.7.3.2. Regulatory framework/reimbursement scenario
      • 6.7.3.3. Argentina pneumatic nebulizers market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.8. MEA
    • 6.8.1. MEA pneumatic nebulizers market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.8.2. South Africa
      • 6.8.2.1. Key country dynamic
      • 6.8.2.2. Regulatory framework/reimbursement scenario
      • 6.8.2.3. South Africa pneumatic nebulizers market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.8.3. Saudi Arabia
      • 6.8.3.1. Key country dynamic
      • 6.8.3.2. Regulatory framework/reimbursement scenario
      • 6.8.3.3. Saudi Arabia pneumatic nebulizers market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.8.4. UAE
      • 6.8.4.1. Key country dynamic
      • 6.8.4.2. Regulatory framework/reimbursement scenario
      • 6.8.4.3. UAE pneumatic nebulizers market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.8.5. Kuwait
      • 6.8.5.1. Key country dynamic
      • 6.8.5.2. Regulatory framework/reimbursement scenario
      • 6.8.5.3. Kuwait pneumatic nebulizers market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Participant Overview
  • 7.2. Company Market Position Analysis
  • 7.3. Company Categorization
  • 7.4. Strategy Mapping
  • 7.5. Company Profiles/Listing
    • 7.5.1. Koninklijke Philips N.V.
      • 7.5.1.1. Overview
      • 7.5.1.2. Financial performance
      • 7.5.1.3. Product benchmarking
      • 7.5.1.4. Strategic initiatives
    • 7.5.2. OMRON Corporation
      • 7.5.2.1. Overview
      • 7.5.2.2. Financial performance
      • 7.5.2.3. Product benchmarking
      • 7.5.2.4. Strategic initiatives
    • 7.5.3. Cook Medical PARI GmbH
      • 7.5.3.1. Overview
      • 7.5.3.2. Financial performance
      • 7.5.3.3. Product benchmarking
      • 7.5.3.4. Strategic initiatives
    • 7.5.4. General Electric
      • 7.5.4.1. Overview
      • 7.5.4.2. Financial performance
      • 7.5.4.3. Product benchmarking
      • 7.5.4.4. Strategic initiatives
    • 7.5.5. Allied Healthcare Products, Inc.
      • 7.5.5.1. Overview
      • 7.5.5.2. Financial performance
      • 7.5.5.3. Product benchmarking
      • 7.5.5.4. Strategic initiatives
    • 7.5.6. BD (Becton, Dickinson & Company)
      • 7.5.6.1. Overview
      • 7.5.6.2. Financial performance
      • 7.5.6.3. Product benchmarking
      • 7.5.6.4. Strategic initiatives
    • 7.5.7. GF Health Products, Inc.
      • 7.5.7.1. Overview
      • 7.5.7.2. Financial performance
      • 7.5.7.3. Product benchmarking
      • 7.5.7.4. Strategic initiatives
    • 7.5.8. Medline Industries, LP
      • 7.5.8.1. Overview
      • 7.5.8.2. Financial performance
      • 7.5.8.3. Product benchmarking
      • 7.5.8.4. Strategic initiatives
    • 7.5.9. Briggs Healthcare
      • 7.5.9.1. Overview
      • 7.5.9.2. Financial performance
      • 7.5.9.3. Product benchmarking
      • 7.5.9.4. Strategic initiatives
    • 7.5.10. Vectura Group Ltd
      • 7.5.10.1. Overview
      • 7.5.10.2. Financial performance
      • 7.5.10.3. Product benchmarking
      • 7.5.10.4. Strategic initiatives